I think FY17 is fully discounted in the price. Given the visibility of earnings, management pedigree, operational history etc I think it is still worth a bet.
Posts tagged Value Pickr
Building of a Fresh Portfolio (28-09-2015)
Generally agree with ur investment logic.. however choice of companies could be debated.. Include Pharma.. lot of good discussions available, identify a basket and atleast 20% of ur portfolio there... same is true for finance.. identify a couple of financial sector companies and invest atleast 15% there.. since u r getting in now, dont be discouraged by high valuations, these companies are expensive for a valid reason and they may continue to do so for sometime to come.. therefore risk mitigation in these companies would be better by doing graduated entry.. waiting for valuations to come down before u invest may not be such a good idea.
Regards
Motherson sumi : Recent opportunity to buy (28-09-2015)
It becomes a long term buy below 200 which I guess will come sooner than expected.
Varun 2020 portfolio – 2 strategies (28-09-2015)
Hi
Portfolio Update-
Finally took positions in Edelweiss Financial services. Hope for a slide in banks tomorrow to load on Axis bank/yes bank for long term.
Strides_Arcolab (28-09-2015)
Jefferies initiates buy rating on the stock with 1500 TP
http://www.financialexpress.com/article/markets/indian-markets/buy-rating-on-strides-arcolab-strides-unique-business-model-likely-to-yield-the-company-dividends/142308/
Strides is looking to raise 1500crore
http://www.businesstoday.in/current/corporate/strides-arcolab-to-raise-up-to-rs-1500-crore-via-various-market-instruments/story/224161.html
8k Miles Software Ltd, Cloud Computing (28-09-2015)
Where does it say 8k miles promoters have reduced their stake?
Torrent Pharma Ltd (28-09-2015)
http://www.sharekhan.com/CMT/Upload/NewsLetter/Report/InvestorsEye-May18_15.pdf
Info from May 2015 report
Minocycline: Torrent Pharma purchased an antibacterial drug, minocycline tablets and capsules, in the USA, which was divested by Ranbaxy Laboratories (Ranbaxy) under the direction of the US competition commission (as a condition of merger with Sun Pharmaceutical Industries). The market size of the product is pegged at $700 million and Ranbaxy held a market share close to 27%. Torrent Pharma has already launched this product in April 2015.
Torrent Pharma Ltd (28-09-2015)
DRL has launched Nexium. I have been reading different numbers on market size of Nexium. Is $5bn post generic-isation?
Cupid Ltd – Helping the world play safe! (28-09-2015)
Is there any update from AGM ? Is it good price to enter after becoming 7 beggar in last 1 year.
Indian terrain—play on consumption (28-09-2015)
As far as i know, QIP money is utilized only to extent of Rs. 16 crores and that too for repayment of debt. Rest all QIP money is parked in liquid funds. I had been to AGM and had personal discussion with CEO, QIP funds would be used for
1. launch of new products like "Indian Terrain Boy", they are planning to also start selling of other men's accessories like "Shoes". So funds will be used for design, product development etc.
2. Advertisement campaigns, they soon are coming up with TV ads.
3. Repayment of long term debt which they have already done and now long term debt is NIL.
On business front, they are confident of increasing their top line by 12-15% and EBIDTA margin by 150-200 bps. That should give decent growth of 25-30% in EBIDTA and added with reduction in long term interest cost of nearly 1.5-2 crores should help achieve PAT increase of 35-40%.